Linkedin
Sign in
Join
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Home
About
Editor’s Corner
Contribute
Contact Us
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
Solutions & Pricing
Partner
Instagram
Linkedin
X
Subscribe
Subscribe
Facebook
Linkedin
X
Youtube
Hot topics
The Evolving Role of HR in Pharma: Why Non-Pharma Backgrounds are Raising the Game
0
The pharmaceutical sector—high-stakes, heavily regulated, and innovation-driven—has historically preferred...
Is America’s “Miracle Shot” Worth the Hype and Risk? A Verified Look at the Claims
0
Introduction:An email circulating from Visibility Nexus references America’s “hottest...
Pharma Marketing in the New Age
0
Inside this Issue 1. Conference Report: Pharma Marketing in the New...
Pharma CEO Roundtable – Engaging Doctors – Physical, Digital and Hybrid: Translating Strategy into Action
0
The MedicinMan 10th Anniversary Special - Pharma CEO Roundtable...
Indian Pharma’s November 2025: How GLP-1s Rewired the Market
0
Indian pharma wrapped up November 2025 with serious velocity....
Facebook
Linkedin
X
Youtube
Healthcare Trends
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Marketing
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Policies/Sales
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Strategy
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Subscribe
Hot topics
Interesting, Engaving & Relevant
0
In this issue Deepak Sharma talks about his journey from Medical Rep to Country Manager. Deeksha Fouzdar presents a case study on implementation of a competency-based HR system in Pharma. Other articles by K. Hariram and Vivek Hattangadi
The Semaglutide Story: How One Molecule Re‑wired Obesity, Patents and Pharma Profits
0
1. From Gut Hormone to “Wonder Drug” If you strip...
Customer Engagement and Experience are the New Differentiators
0
At the IDMA Marketing and Sales Conference in Mumbai...
What’s the Mood of Indian Pharma? A Poll by MedicinMan
0
We are in the middle of huge crisis and...
Tariffs and Indian Generics: Is Trump Cutting His Nose to Spite His Face?
0
Trump’s Tariffs Threaten US Drug Affordability The Value of...
Facebook
Linkedin
X
Youtube
Healthcare Trends
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Marketing
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Policies/Sales
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Strategy
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Subscribe
Home
DSC_6774
DSC_6774
DSC_6774
